Superficial Radiotherapy: Long Term Follow-Up of Highly Selected Basal and Squamous Cell Carcinomas in Skin Cancer Patients
Superficial radiotherapy (SRT) treatment for non-melanoma skin cancer has been reported to yield variable cure rates. When patients are highly selected, adequate margins of treatment are chosen, and hypofractionation is avoided, cure rates of SRT can approach that of Mohs surgery.
SCARS Center’s research article on the subject was recently published in Journal of Dermatology and Skin Science. See full article here:
Journal of Dermatology and Skin Science
(A) Superficial ulceration 2 weeks after completion of a 3 week course of SRT (15 fractions), unusually severe hypopigmentation and skin atrophy 3 years after treatment.
(B) Superficial ulceration of the right cheek and chin 3 weeks after completion of a 3 week course of SRT (15 fractions), patchy hypopigmentation and skin atrophy 1 year after treatment.
(C) Superficial ulceration 2 weeks after completion of a 3-week course of SRT (15 fractions), flaky scaling of healed skin 4 weeks after completion of SRT.
